Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
506.00    -6.00 (-1.17%)
Bid:
506.00
Ask:
510.00
Spread: 4.00 (0.791%)
Market Cap: £835.99m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Trading Update

31 Jan 2018 07:00

RNS Number : 4053D
Oakley Capital Investments Limited
31 January 2018
Ā 

31 January 2018

Ā 

Oakley Capital Investments Limited

Ā 

Trading update for the twelve months ended 31 December 2017

Ā 

Oakley Capital Investments Limited1 (AIM:OCI, the "Company"), which provides its shareholders with access to a portfolio of high quality companies through its investments in the Oakley Funds2, today announces a trading update for the 12 months ended 31 December 2017.

Ā 

· NAV per share (unaudited) expected to be in the range of £2.43 - £2.45, representing an increase of at least 5% on December 2016 (£2.31)

· The Company has deployed £157.0m in the Oakley Funds and equity co-investments in 2017, during a period of significant investment

· The Company received £88.2m of distributions in the period

Ā· Fund III closed at €800m in September 2017 of which the Company committed €326m

Ā· Interim dividend ofĀ 2.25 pence, paid on 26 October 2017

Ā 

Oakley Capital Limited ("Oakley Capital"), the Company's Investment Adviser, estimates that the Company's net asset value ("NAV"), which is subject to the completion of the 31 December 2017 audit of both the Oakley Funds and the Company, will be in the range of £498m to £502m, equating to a NAV per share of £2.43 to £2.45 (31 December 2016: £2.31).

Ā 

Fund III has been active in deploying its capital and has invested €310.2m in five investments during the year, and completed another acquisition in January 2018 investing a further €84.6m. These portfolio companies represent investments in digital consumer, education and technology assets. The average entry EV/EBITDA multiple in Fund III, across all six assets, is currently 9.4x, reflecting the Investment Adviser's continued ability to access quality assets at attractive prices. OCI has an indirect interest in these portfolio companies through its 40.7% holding in Fund III.

Ā 

During the year, the Company received £88.2m of distributions from the Oakley Funds and equity co-investments, relating to exits and refinancings.

Ā 

The Company expects to report its annual results for 2017 on Thursday 15 March 2018.

Ā 

Ā 

- This announcement contains inside information -

Ā 

Ā 

For further information please contact:

Ā 

Oakley Capital Investments Limited

+44 20 7766 6900

Peter Dubens, Director

Steven Tredget, Investor Relations

Ā 

FTI Consulting LLP

+44 20 3727 1000

Edward Bridges / Stephanie Ellis

Ā 

Liberum Capital Limited (Nominated Adviser & Broker)

+44 20 3100 2000

Steve Pearce / Henry Freeman / Jill Li

Ā 

Ā 

1 About Oakley Capital Investments Limited ("OCI")

Oakley Capital Investments Limited is a Bermudian company listed on AIM. OCI seeks to provide investors with long term capital appreciation through its investment in Oakley Capital Private Equity L.P., Oakley Capital Private Equity II, Oakley Capital Private Equity III and through co-investment opportunities.

Ā 

LEI Number: 213800KW6MZUK12CQ815

Ā 

2 About Oakley Capital Private Equity L.P. ("Fund I"), Oakley Capital Private Equity II ("Fund II") and Oakley Capital Private Equity III ("Fund III") collectively the "Oakley Funds"

Oakley Capital Private Equity L.P. and its successor funds, Oakley Capital Private Equity II and Oakley Capital Private Equity III, are unlisted mid-market private equity funds with the aim of providing investors with significant long term capital appreciation. The investment strategy of the funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement.

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
TSTSDFEESFASEEF
Date   Source Headline
23rd Feb 20217:00 amRNSNotice of Results and Investor Presentation
19th Feb 20217:00 amRNSInvestment in Dexters
10th Feb 20217:00 amRNSDirector Dealing
29th Jan 20214:42 pmRNSDirector Dealing
27th Jan 20215:06 pmRNSDirector Dealing
27th Jan 20217:00 amRNSTrading update for the year ended 31 December 2020
26th Jan 20217:00 amRNSInvestment in idealista
7th Jan 20217:00 amRNSSale of the DWS division of the Daisy Group
22nd Dec 20204:11 pmRNSHolding(s) in Company
11th Dec 20202:33 pmRNSDirector Declaration
4th Dec 20203:58 pmRNSHolding(s) in Company
3rd Dec 20204:50 pmEQSHardman & Co Research: Oakley Capital Investments (OCI): NAV: conservative, robust and with growth upside
3rd Dec 20201:52 pmRNSTransaction in Own Shares
25th Nov 20207:00 amRNSHolding(s) in Company
23rd Oct 20207:00 amRNSDirector/PDMR Shareholding
22nd Oct 20207:00 amRNSAcquisition of WindStar Medical
6th Oct 202012:42 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSTransaction in Own Shares (Amendment)
2nd Oct 20204:33 pmRNSTransaction in Own Shares
2nd Oct 20207:00 amRNSShare Buy-Back Programme
1st Oct 20207:00 amRNSAcquisition of 7NXT
30th Sep 20201:54 pmRNSAppointment of Non-Executive Director
17th Sep 20207:00 amRNSOakley sells Casa.it to EQT
10th Sep 20207:00 amRNSResults for the six months ended 30 June 2020
1st Sep 20207:20 amEQSHardman & Co Research: Oakley Capital Investments (OCI) - initiation of coverage: 'When it rains gold, put out the bucket'
4th Aug 20203:09 pmRNSHolding(s) in Company
29th Jul 20206:15 pmRNSTransaction in Own Shares
29th Jul 20207:00 amRNSTrading update for the six months ended 30 June 20
15th Jul 20209:30 amRNSKepler Trust Intelligence: New Research
6th Jul 20207:00 amRNSCapital Commitment
30th Jun 20207:00 amRNSDirectorate Change
24th Jun 20206:02 pmRNSDirector Dealing
22nd Jun 202012:22 pmRNSHolding(s) in Company
19th Jun 20205:38 pmRNSDirector Dealing
19th Jun 20207:01 amRNSDirector Dealing
19th Jun 20207:00 amRNSDirector Dealing
18th Jun 20205:57 pmRNSHolding(s) in Company
18th Jun 20204:42 pmRNSTransaction in Own Shares
18th Jun 20207:00 amRNSShare Buy-Back
1st Jun 20202:25 pmRNSDirector Declaration
27th May 20205:01 pmRNSHolding(s) in Company
27th May 20207:00 amRNSResult of Annual General Meeting
22nd May 20204:33 pmRNSTime Out equity fundraise and OCI loan repayment
19th May 20207:00 amRNSDirector Declaration
7th May 20207:00 amRNSDirectorate Change and Total Voting Rights
1st May 20207:00 amRNSNotice of Annual General Meeting
8th Apr 20207:00 amRNSOakley completes sale of investment in Inspired
25th Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20207:00 amRNSAnnual Report and Accounts 2019
18th Mar 20204:22 pmRNSTransaction in own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.